Siga Technologies INC Total Long-Term Debt
Siga Technologies INC (SIGA) had Total Long-Term Debt of $78.91 million as of 2019-09-30, per its 10-Q filed 2019-11-05.
Discontinued › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:LongTermDebt · last filed 2019-11-05
- 2019-09-30: Long-term Debt $78.91M.
- 2019-06-30: Long-term Debt $77.78M.
- 2019-03-31: Long-term Debt $76.66M.
- 2018-12-31: Long-term Debt $75.55M.
| Period end | Long-term Debt |
|---|---|
| 2019-09-30 | $78.91M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $77.78M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $76.66M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $75.55M 10-Q · filed 2019-11-05 |
| 2018-09-30 | $74.41M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $73.28M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $72.16M 10-Q · filed 2018-05-04 |
| 2017-12-31 | $71.05M 10-Q · filed 2018-11-06 |
| 2017-09-30 | $69.92M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $68.78M 10-Q · filed 2017-08-03 |
| 2016-12-31 | $66.55M 10-Q · filed 2017-11-07 |
| 2014-12-31 | $1.99M 10-K · filed 2015-03-06 |
| 2014-09-30 | $2.50M 10-Q · filed 2014-11-04 |
| 2013-12-31 | $3.96M 10-K · filed 2014-03-10 |
| 2012-12-31 | $5.00M 10-K/A · filed 2013-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |